Encinitas, CA, United States of America

Wesley K M Chong


Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Wesley K M Chong: Innovator in Pharmaceutical Development

Introduction

Wesley K M Chong is a notable inventor based in Encinitas, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. With a total of 4 patents to his name, his work has had a meaningful impact on medical research and drug development.

Latest Patents

Chong's latest patents include innovative compounds such as substituted 4-amino-thiazol-2-yl compounds, which serve as cyclin-dependent kinase inhibitors. Additionally, he has developed metalloproteinase inhibitors, along with pharmaceutical compositions that contain these compounds and their various uses. These inventions highlight his commitment to advancing therapeutic options in medicine.

Career Highlights

Throughout his career, Wesley K M Chong has worked with Agouron Pharmaceuticals, Inc., where he contributed to groundbreaking research and development projects. His expertise in pharmaceutical sciences has positioned him as a key player in the industry, driving forward the development of new and effective treatments.

Collaborations

Chong has collaborated with several professionals in the field, including Steven Lee Bender and Arlindo Lucas Castelhano. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new pharmaceutical solutions.

Conclusion

Wesley K M Chong's contributions to pharmaceutical innovation are noteworthy, with a focus on developing compounds that address critical medical needs. His work continues to influence the landscape of drug development and therapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…